BioNTech SE (BNTX) Misses Q2 EPS by 19c; reaffirms guidance

 BioNTech SE (NASDAQ: BNTX) reported Q2 EPS of (EUR1.60), EUR0.19 worse than the analyst estimate of (EUR1.41). Revenue for the quarter came in at EUR260.8 million versus the consensus estimate of EUR137.9 million.

GUIDANCE:

BioNTech SE sees FY2025 revenue of EUR1.7-2.2 billion, versus the consensus of EUR2.27 billion.

https://www.streetinsider.com/Earnings/BioNTech+SE+%28BNTX%29+Misses+Q2+EPS+by+19c%3B+reaffirms+guidance/25139436.html